Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells
Giulia Angelini(Università Cattolica del Sacro Cuore), Filippo Crea(Università Cattolica del Sacro Cuore), Aureliano Ruggio(Università Cattolica del Sacro Cuore), Giovanna Liuzzo(Agostino Gemelli University Polyclinic), Daniela Pedicino(Agostino Gemelli University Polyclinic), Francesco Trotta(Italian Medicines Agency), Giuseppe Pio Piemontese(Università Cattolica del Sacro Cuore), Myriana Ponzo(Università Cattolica del Sacro Cuore), Davide Flego(Università Cattolica del Sacro Cuore), Luigi M. Biasucci(Agostino Gemelli University Polyclinic), Domenico Galante(Università Cattolica del Sacro Cuore), Ramona Vinci(Unknown)
Cited by 36
Related Papers
Ischemia and No Obstructive Coronary Artery Disease (INOCA)
|Circulation|2017|745
Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial
|The Lancet|2023|338
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials
|European Heart Journal|2021|150
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
|Frontiers in Physiology|2019|130